No Data
No Data
Huakang Medical (301235.SZ): Its medical consumables business has adopted SPD supply chain extended service system.
On July 26th, Gelonhui reported that an investor asked Huakang Medical (301235.SZ) on the investor interactive platform, "Has the company's medical consumables business adopted SPD's supply chain extended service system?" The company responded that the medical consumables business has adopted SPD's supply chain extended service system. The company will use this as a carrier to further improve services, strengthen information interconnectivity and collaborative interaction with suppliers and customers, and promote the development of company operations and business.
Huakang Medical (301235.SZ) signed a termination agreement for a procurement contract with Yueyang Central Hospital.
On July 26th, Gelunhui reported that Huakang Medical (301235.SZ) recently signed a "Termination Agreement" with Yueyang Central Hospital regarding the government procurement contract for the hospital's medical special purification project and outpatient and emergency medical technology complex building (outpatient medical technology building-fifth floor surgery center, ICU, and neurocritical care unit) for the inpatient department. After the original contract was signed, due to many objective factors, the project construction was delayed and has not been carried out. After friendly consultation between the two parties, the company and Yueyang Central Hospital signed a "Termination Agreement", unanimously agreeing to terminate the original contract on July 25, 2024. End.
Huakang Medical (301235.SZ): As of June 28, the total number of shareholders of the company was 9334.
On July 4th, Gelonhui reported that as of June 28th, 2024, there were a total of 9,334 shareholders in Huakang Medical (301235.SZ) according to the investor interaction platform.
Huakang Medical (301235.SZ) has won the bid for the medical special equipment and material procurement and installation project of the Traditional Chinese Medicine Inheritance and Innovation Engineering of Jiangxi Traditional Chinese Medicine University A
On July 3rd, Gelunhui announced that on July 2nd, 2024, the company received a 'Notice of Winning Bid' from Jiangxi University of Traditional Chinese Medicine Affiliated Hospital, confirming the company as the winning supplier of the 'Medical Special Equipment and Material Procurement and Installation Project for the Traditional Chinese Medicine Inheritance and Innovation Project of Jiangxi University of Traditional Chinese Medicine Affiliated Hospital'. The winning bid was 73,999.96 yuan.
As of June 20, 2024, the total number of shareholders for Huakang Medical (301235.SZ) was 9273.
On June 26, Gelunhui reported that Huakang Medical (301235.SZ) stated on the investor interaction platform that as of June 20, 2024, the total number of shareholders in the company was 9,273.
Huakang Medical (301235.SZ): plans to establish a joint venture with Guanggu Health Investment.
On June 21st, Gelunhui announced that Huakang Medical (301235.SZ) plans to jointly invest with Wuhan Optics Valley Health Industry Investment Co., Ltd. (referred to as 'Optics Valley Health Investment') to establish a joint venture, Wuhan Optics Valley Health Medical Services Co., Ltd. The registered capital of the joint venture is RMB 100 million, of which the company plans to use its own funds to subscribe for RMB 80 million, holding an 80.00% stake. Optics Valley Health Investment will subscribe for RMB 20 million, holding a 20.00% stake. Since early 2024, the controlling shareholder and actual controller Tan Pingtao
No Data